DailyIQ
Last updated 3 minutes ago

BWXT·BWX Technologies Inc.

$.
+. (+.%)
After Hours
High
$173.99
Open
$171.78
Market Cap
15.70B
52W High
$241.82
Low
$168.32
P. Close
$169.56
P/E
45.56
52W Low
$136.18
Fwd P/E
163.79
DailyIQ Est.
$246.77
Technical Score (1D)
14
SELL
News Sentiment
42
BEARISH
The most recent comparison shows BWXT’s $4.9 billion net loss and negative free cash flow, underscoring heavy R&D spending and contract uncertainty in the defense sector and raising concerns about near‑term liquidity and capital allocation. Earlier this week, the company’s Q1 earnings matched industry averages, with modest revenue growth but effective cost controls that preserved margins, indicating operational stability amid defense budget cycles. At the same time, BWXT reported a revenue beat that exceeded consensus, driven by geopolitical tensions that lift defense spending, yet its guidance for the next quarter is slightly below consensus, hinting at a potential slowdown. In late June, BWXT completed its acquisition of Precision Components Group, expanding U.S. heavy‑manufacturing capacity for nuclear components, which should broaden its commercial nuclear footprint and reduce reliance on defense contracts. The acquisition also prompted removal from several defensive indexes, signaling a shift in risk perception and potentially increasing beta and liquidity flows. Analysts have upgraded BWXT to buy after the acquisition and strong Q1 results, raising 2026 guidance, but Argus Research recently lowered its price target to $206 due to concerns over slower revenue growth and margin compression in the nuclear materials sector. The company’s ongoing investment in manufacturing equipment to boost production for advanced reactors positions it to capture rising demand, but the speed of ramp‑up and integration costs remain key watch items. Traders should monitor the next earnings release for confirmation of guidance, any updates on Precision Components integration, and shifts in defense spending that could affect revenue. Additionally, watch for potential index rebalancing flows that may alter liquidity and beta as the stock exits defensive categories.
Earnings Summary
BWXT Technologies, Inc. (BWXT) is a global provider of specialized nuclear components and services, focusing on the design, manufacture, and servicing of reactors, fuel, and related equipment for government and commercial customers, including the U.S. Navy and commercial nuclear power plants. Operating within the industrials sector and the aerospace & defense industry, the company’s diversified customer base spans naval, research, and commercial nuclear applications, positioning it to benefit from both defense spending and commercial nuclear growth. In its most recent reporting period, BWXT delivered earnings per share of $1.08 in Q4 2025, surpassing the $0.88396 estimate, and generated $885.84 million in revenue, beating the $837.47 million forecast; the following quarter’s results continued the trend with an EPS of $1.12 versus a $0.9443 estimate and revenue of $860.22 million versus a $855.46 million projection, underscoring a consistent pattern of earnings beats over the last four quarters. Historically, BWXT has maintained a streak of outperforming analyst expectations, with EPS growth outpacing estimates and revenue growth remaining positive despite a slight dip in the most recent quarter, indicating a resilient earnings trajectory. Recent news highlights the completion of the Precision Components Group acquisition, which expands BWXT’s heavy‑manufacturing footprint and adds complex component production for commercial nuclear life‑extension and new‑build projects, and the long‑term supply agreement with ATI that secures key materials for the U.S. Naval Nuclear Propulsion Program; these developments have prompted index rebalancing and fresh buy calls, reinforcing a more diversified growth outlook. Investors should watch the upcoming Q2 2026 filing for updated guidance on revenue, operating margins, and the progress of the Precision Components integration, as well as any new contract awards or backlog updates that could confirm the commercial expansion narrative, and monitor the impact of the ATI supply agreement on production capacity and cost structure, as these factors will likely shape the next earnings narrative.

EPS

EstBeatMiss
$0.71$0.83$0.94$1.06$1.17Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.04 - -
Q1'26$0.94$1.12+18.6%
Q4'25$0.88$1.08+22.2%
Q3'25$0.87$1.00+14.3%
Q2'25$0.79$1.02+28.7%
Q1'25$0.76$0.91+19.0%

Revenue

EstBeatMiss
$646M$724M$801M$879M$956MQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$921M - -
Q1'26$855M$860M+0.6%
Q4'25$837M$886M+5.8%
Q3'25 - $866M -
Q2'25 - $764M -
Q1'25 - $682M -

Market Data

BWXT Stock Snapshot

BWXT is currently trading at $173.05, giving BWX Technologies Inc. a market cap of 15.70B and a P/E ratio of 45.6. Today's range spans $168.32–$173.99, with shares opening at $171.78 and moving up $3.49 (2.1%) from the prior close. DailyIQ's technical score sits at 14/100 (SELL) with a news sentiment reading of 42/100.

Over the past year BWXT has traded between $136.18 and $241.82 - the current price is +27.1% off the 52-week low and -28.4% from the high. 23 analysts cover the stock with a Buy consensus and a mean 12-month target of $238.79 (range $200.00–$290.00), implying upside of +38.0%.

The bearish momentum on BWX Technologies Inc. (BWXT) - 14/100 (SELL), sentiment neutral at 42/100, price $173.05 (in the lower half of its 52-week range) - is the type of setup where stop-loss selling from long-side momentum strategies amplifies the initial technical weakness. The current P/E ratio stands at 45.6. At 15.70B in Industrials market cap, the 52-week range of $136.18–$241.82 provides the structural reference, and the lower end of that range becomes the next key test if the current SELL signal persists.

Analyst coverage for BWXT becomes a double-edged factor in a SELL phase: at 15.70B in Industrials market cap, active coverage is high enough that downgrade risk is real and impactful. The 14/100 technical reading and neutral sentiment (42/100) at $173.05 (in the lower half of its 52-week range) place the stock in the zone where one or two high-profile estimate cuts can convert a grinding decline into a sharper re-rating — the $136.18–$241.82 range establishes where that repricing lands.